Safety Profile? I heard the two cardiac safety iss
Post# of 148158
I also heard Amarex wasn't tracking safety (was it in HIV trials) going back some length of time and will have to be verified for the FDA.
Does this mean we may not have the safety profile we thought we had? Did we state over and over we had no SAEs all the while that Amarex wasn't tracking SAEs?
Hope not. I've invested heavily here because of the safety profile, and to not have 100% confidence in that right now is less than optimal.
Safety of LL is kindsa bedrock. Or is it? Perhaps I'm over-thinking here? Thoughts?